Related Experiment Video
Updated: Mar 22, 2026

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
PrEFiNe Plan: Strategic plan for Fabry diseases in Nephrology
M D Del Pino1, A Ortiz2, R Torra3
1Servicio de Nefrología, Hospital Torrecárdenas, Almería, España.
Fabry disease (FD) often leads to renal failure due to delayed diagnosis. The PrEFiNE project aims to improve FD knowledge and diagnosis for earlier recognition and prevention of complications.
Area of Science:
- Nephrology
- Rare Diseases
- Genetic Disorders
Background:
- Renal failure is a primary cause of mortality in Fabry disease (FD) patients.
- Delayed diagnosis and misdiagnosis are common in FD, often leading to irreversible organ damage.
- Early recognition of FD is crucial for preventing severe complications and premature death.
Purpose of the Study:
- The PrEFiNE project aims to enhance knowledge and diagnosis of Fabry disease.
- This initiative seeks to improve the early identification of FD to mitigate its severe consequences.
Main Methods:
- A multi-faceted approach including surveys of nephrologists' FD knowledge and prevalence studies in dialysis, transplant, and predialysis CKD patients.
- Pharmacoeconomic analysis of FD burden and online/on-site medical education activities.
- Dissemination through publications, media, and a final compilation book with recommendations.
Main Results:
- The PrEFiNE project will assess an action plan to improve FD knowledge and facilitate early diagnosis.
- The project will identify and address unmet needs in FD management and patient care.
Conclusions:
- The PrEFiNE project is designed to improve the early recognition of Fabry disease.
- Recommendations will be developed based on project findings to address undetected needs in FD care.
More Related Videos
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease IV: Nursing Management
Nephrotic Syndrome III : Nursing Management
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate